Patrick Michl Selected Research

4- aminophenyl- 1,2- dihydro- 1- methyl- 2- propylcarbamoyl- 6,7- methylenedioxyphthalazine

8/2010

Glutamate receptor GRIA3--target of CUX1 and mediator of tumor progression in pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrick Michl Research Topics

Disease

26	Neoplasms (Cancer) 04/2022 - 06/2005
25	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022 - 10/2003
9	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2022 - 02/2012
7	Chronic Pancreatitis 10/2021 - 01/2016
6	Neoplasm Metastasis (Metastasis) 12/2017 - 10/2003
5	Primitive Neuroectodermal Tumors (PNET) 11/2021 - 02/2012
5	Adenocarcinoma 07/2020 - 01/2016
4	Carcinogenesis 05/2021 - 01/2006
3	COVID-19 01/2022 - 07/2020
3	Insulinoma 01/2021 - 10/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2016
2	Pancreatitis 10/2020 - 10/2018
2	Carcinoid Tumor (Carcinoid) 06/2016 - 09/2014
1	Hemorrhage 01/2021
1	Pain (Aches) 10/2020
1	Infections 07/2020
1	Critical Illness (Critically Ill) 04/2020
1	Pancreatic Diseases (Pancreatic Disease) 03/2020
1	Inflammation (Inflammations) 01/2019
1	Abdominal Pain (Pain, Abdominal) 01/2019
1	Acute Abdomen 01/2019
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2018
1	Colitis 01/2018
1	Disease Progression 12/2017
1	Lymphatic Metastasis 12/2017
1	Esophageal Neoplasms (Esophageal Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

7	Gemcitabine FDA Link 08/2021 - 02/2013
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2010
5	Pharmaceutical PreparationsIBA 07/2020 - 10/2012
5	Proteins (Proteins, Gene)FDA Link 06/2020 - 12/2010
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 04/2022 - 01/2020
3	Messenger RNA (mRNA)IBA 04/2022 - 01/2020
3	Biological ProductsIBA 02/2022 - 01/2018
3	Dacarbazine (DIC)FDA LinkGeneric 11/2021 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 05/2021 - 01/2013
3	CathepsinsIBA 09/2020 - 06/2012
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020 - 02/2012
3	CytokinesIBA 01/2017 - 12/2013
3	Streptozocin (Streptozotocin)FDA Link 01/2017 - 01/2015
3	Claudin-4IBA 05/2015 - 10/2003
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2006 - 10/2003
2	Calcium-Sensing ReceptorsIBA 10/2021 - 10/2020
2	130-nm albumin-bound paclitaxelIBA 08/2021 - 01/2021
2	Protein Isoforms (Isoforms)IBA 05/2021 - 10/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 09/2020 - 01/2016
2	Carrier Proteins (Binding Protein)IBA 06/2020 - 01/2020
2	Lipase (Acid Lipase)FDA Link 04/2020 - 01/2016
2	EstersIBA 04/2020 - 01/2016
2	MicroRNAs (MicroRNA)IBA 01/2020 - 06/2016
2	Clodronic Acid (Clodronate)IBA 10/2018 - 01/2017
2	Trastuzumab (Herceptin)FDA Link 12/2017 - 01/2017
2	Sunitinib (Sutent)FDA Link 01/2017 - 02/2012
2	Alkylating AgentsIBA 01/2017 - 01/2017
2	Everolimus FDA Link 01/2017 - 02/2012
1	Histones (Histone)IBA 04/2022
1	Lysine (L-Lysine)FDA Link 04/2022
1	Polycomb Repressive Complex 2IBA 04/2022
1	atezolizumabIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	CateninsIBA 01/2022
1	cyclopropapyrroloindoleIBA 01/2022
1	RamucirumabIBA 11/2021
1	Radioisotopes (Radionuclides)IBA 07/2021
1	Peptide Receptors (Peptide Receptor)IBA 07/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2021
1	Polidocanol (Laureth)FDA Link 01/2021
1	PanobinostatIBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	ChymotrypsinogenIBA 12/2020
1	Analgesics (Analgesic Drugs)IBA 10/2020
1	CalciumIBA 10/2020
1	InflammasomesIBA 10/2020
1	AerosolsIBA 07/2020
1	Galectin 3 (LGALS3)IBA 03/2020
1	Advanced Glycation End ProductsIBA 03/2020
1	E2F Transcription FactorsIBA 01/2020
1	Lactoylglutathione LyaseIBA 01/2019
1	antiarrhythmic peptide (AAP)IBA 01/2019
1	TrypsinogenIBA 10/2018
1	Liposomes (Liposome)IBA 10/2018
1	Panitumumab (Vectibix)FDA Link 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	lanreotide (Somatuline)FDA Link 01/2017
1	Chromogranin AIBA 01/2017
1	Temozolomide (Temodar)FDA LinkGeneric 01/2017
1	AntimetabolitesIBA 01/2017
1	N- (3,4- difluoro- 2- (2- fluoro- 4- iodophenylamino)- 6- methoxyphenyl)- 1- (2,3- dihydroxypropyl)cyclopropane- 1- sulfonamideIBA 01/2017
1	Growth Hormone (Somatotropin)IBA 06/2016

Therapy/Procedure

22	Therapeutics 04/2022 - 10/2010
11	Drug Therapy (Chemotherapy) 11/2021 - 02/2012
3	Neoadjuvant Therapy 08/2021 - 01/2017
1	Immunotherapy 01/2022
1	Sclerotherapy 01/2021
1	Pain Management 10/2020
1	Personal Protective Equipment 07/2020
1	Enteral Nutrition (Feeding, Tube) 04/2020
1	Combination Drug Therapy (Combination Chemotherapy) 01/2018
1	Enema (Enemas) 01/2018
1	Combined Modality Therapy 01/2017